摘要
本文介绍国家二类抗癌新药康莱特注射液的抗肿瘤作用机制,以及其在肺癌外科治疗中的应用概况,肯定其疗效确切、安全可靠且治疗费用相对低廉的良好临床应用价值。康莱特不仅能够有效控制肺癌患者病灶,还可以提高肺癌患者术后的机体免疫力、促进术后恢复;康莱特联合顺铂治疗癌性胸腔积液,与单用药相比不仅能提高临床疗效,更能减少不良反应的发生。康莱特在肺、肝、脑、乳腺肿瘤等多种癌症治疗中均观察到较好疗效,值得临床推广应用。
This study introduces the antitumor mechanisms of Kanglaite injection and its applications in lung cancer surgery. The obvious curative effect of the treatment, as well as its safety, reliability, and low cost, can be assessed with positive results. Kanglaite in- jection can stop the development of lung cancer and help patients recover their health after the operation. The therapeutic effect of Kan- glaite injection combined with cisplatin was better than when these treatments were used individually. In addition, the combined thera- py had few adverse reactions. The positive curative effects of using Kanglaite injection were observed for several chemotherapeutic regimens, thus, further clinical applications are recommended,
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2012年第16期1155-1157,共3页
Chinese Journal of Clinical Oncology
关键词
肺癌外科
康莱特注射液
临床应用
Lung cancer surgery
Kanglaite injection
Clinical application